Delivery Order SPE2DB25D7068-SPE2DB25FTYAH
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,789.72 for 500 tablets of Topiramate 25 mg, with a completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency has awarded a delivery order valued at $35,132.55 to AmerisourceBergen Drug Corp for the supply of Topiramate 25 mg tablets in quantities of 500 units. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of August 5, 2025, and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $5,076.43 to AmerisourceBergen Drug Corp for 500 tablets of Topiramate 25 mg, with an ultimate completion date of August 28, 2025. This competitive award, executed on August 27, 2025, utilizes firm fixed pricing and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,032.61 to AmerisourceBergen Drug Corp for 500 tablets of Topiramate 25 mg. The contract, which became effective on August 18, 2025, with an ultimate completion date of August 19, 2025, utilizes firm fixed price pricing and was awarded without a set-aside designation. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of 500 tablets of Topiramate 25 mg at a ceiling value of $8,738.79. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The contract is set for completion by September 15, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of 1,000 units of Topiramate 100mg at a firm fixed price of $1,566.48. This is a non-set-aside, competitively awarded contract with an ultimate completion date of September 13, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order, which falls under a larger indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $7,564.11 to AmerisourceBergen Drug Corp for the supply of Topiramate 25 mg tablets in quantities of 500 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 15, 2025, and was awarded on September 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order valued at $5,177.90 to AmerisourceBergen Drug Corp for the supply of 500 tablets of Topiramate 25 mg. This contract, which was competitively awarded without set-aside designation, represents a firm fixed-price delivery order with an ultimate completion date of June 6, 2025. The vendor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award is a child contract derived from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Topiramate 50 mg tablets in quantities of 1,000 units, valued at $2,393.22 with a firm fixed-price structure. This award represents a non-competed delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The contract will be performed at...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $1,099.68 from the Defense Logistics Agency's Medical Supply Chain to supply 1,000 units of Topiramate 25mg. The contract was competitively awarded on June 7, 2025, with a firm fixed price structure and no set-aside designation. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- SPE2DB25D7068Indefinite Delivery Contract
- SPE2DB25D7068-SPE2DB25FTYAHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,005.03 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Topiramate 100 mg. This contract, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies a comprehensive range of medications and medical products to support military healthcare programs, the Defense Health Agency, and other government systems. Topiramate, an anticonvulsant medication, falls within the company's extensive portfolio of neurological treatments and specialty pharmaceuticals provided through its competitively awarded federal contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/18/25 |